The Children’s Tumor Foundation’s bold and collaborative approach to advancing research and accelerating treatments for NF was recently spotlighted on RareCast, the Global Genes podcast that explores where rare disease meets business, policy, and science.
In this episode, CTF CEO Annette Bakker, PhD, discusses how the Foundation partners with drug developers to bring new therapies to the NF community—including efforts to reposition existing drug candidates originally developed for other conditions. The conversation delves into the complexities of NF, the power of cross-sector collaboration, and how CTF’s strategic model can inspire and inform the work of other organizations.
“If you can get one drug approved, you can get more drugs approved.”
Listen: Online | Spotify | Apple Podcasts
